Cure My Disease

Don't miss your cure!

 Log in / Sign up

A healing hand: could Doula-Midwife teams transform postpartum recovery for NICU moms?

NCT ID NCT07787845

Symptom relief Sponsor: University of South Carolina Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether a coordinated care approach—where doulas provide continuous emotional and physical support and nurse-midwives deliver specialized postpartum care—can improve health outcomes for mothers whose babies are born before 34 weeks and admitted to the NICU. Participants will be randomly assigned to receive either this integrated support or standard postpartum care. The study will measure how quickly mothers receive postpartum care, their mental health, and their overall well-being in the months after birth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Doula-coordinated, midwife-delivered postpartum care
What this could lead to
If effective, this integrated care model could reduce postpartum complications, improve mental health, and enhance recovery for mothers of preterm infants.
What could go wrong
This is a behavioral intervention, so results may vary by setting and participant engagement. The trial is not a drug study, so benefits may be modest and depend on implementation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age above 18 at time of delivery of infant * English-speaking * Medicaid insurance coverage at the time of delivery, either as primary or secondary coverage * Delivery before 34 weeks' gestation * Infant admitted to the NICU, 10 days old or less Exclusion Criteria: * Stillbirth * Infant death in the delivery room * Infant with severe congenital anomalies expected to result in death shortly after birth * Inability to provide informed consent * Inability to visit the infant in the NICU at least once per week * More than 10 days postpartum

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Doula support are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postpartum depression Premature Birth Psychological Well-Being puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Doula support Postpartum Postpartum anaemia Postpartum depression (PPD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Prisma Health Richland

    Columbia, South Carolina, 29203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.